Literature DB >> 16483000

Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.

Anne Clairotte1, Isabelle Lascombe, Sylvie Fauconnet, Frédéric Mauny, Sophie Félix, Marie-Paule Algros, Hugues Bittard, Bernadette Kantelip.   

Abstract

Loss of intercellular adhesion facilitates tumor invasion. To clarify the relation between altered expression of cell adhesion molecules and progression of T1 superficial bladder tumors, 101 cases (71 T1 tumors, 30 T2/T3 tumors) were examined immunohistochemically for E-cadherin and alpha-, beta-, and gamma-catenins. A highly significant correlation was observed between the decreased expression of all molecules and increased TNM stage (P < .001). Univariate analysis, performed in cases of T1 tumors, revealed association of abnormal E-cadherin with beta-catenin diminution. Survival curves were established with the Kaplan-Meier method and analyzed according to clinical and histopathologic parameters using the log-rank test. Cox multivariate analysis revealed only gamma-catenin as an independent predictor of progression-free survival in patients with stage T1 bladder urothelial tumors. The characterization of T1 tumors that will progress could lead to the identification of patients who might benefit from surgery to avoid vesical muscle invasion and, consequently, metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483000

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Relation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder.

Authors:  Serkan Senol; Asif Yildırım; Ibrahim Akalin; Fatih Uruç; Bengü Çobanoğlu; Sarenur Yilmaz; Bahar Ceyran; Duygu Kösemetin; Dilek Ece; Abdullah Aydın
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.

Authors:  Johannes Breyer; Michael Gierth; Sanzhar Shalekenov; Atiqullah Aziz; Julius Schäfer; Maximilian Burger; Stefan Denzinger; Ferdinand Hofstädter; Christian Giedl; Wolfgang Otto
Journal:  World J Urol       Date:  2015-09-22       Impact factor: 4.226

Review 3.  Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

Authors:  George J Netto
Journal:  Nat Rev Urol       Date:  2011-12-13       Impact factor: 14.432

Review 4.  Emerging critical role of molecular testing in diagnostic genitourinary pathology.

Authors:  George J Netto; Liang Cheng
Journal:  Arch Pathol Lab Med       Date:  2012-04       Impact factor: 5.534

5.  WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.

Authors:  Wolfgang Otto; Johannes Breyer; Sonja Herdegen; Fabian Eder; Simone Bertz; Matthias May; Roman Mayr; Eva M Lausenmeyer; Stefan Denzinger; Bas W G van Rhijn; Maximilian Burger; Arndt Hartmann
Journal:  Int Urol Nephrol       Date:  2016-12-29       Impact factor: 2.370

Review 6.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

7.  Plakoglobin: role in tumorigenesis and metastasis.

Authors:  Zackie Aktary; Manijeh Pasdar
Journal:  Int J Cell Biol       Date:  2012-03-08

8.  The clinical significance of γ-catenin in acute myeloid leukemia.

Authors:  Jiadai Xu; Wei Wu; Wenyi Shen; Peng Liu
Journal:  Onco Targets Ther       Date:  2016-06-27       Impact factor: 4.147

9.  Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.

Authors:  Tanja Spethmann; Lukas Clemens Böckelmann; Vera Labitzky; Ann-Kristin Ahlers; Jennifer Schröder-Schwarz; Sarah Bonk; Ronald Simon; Guido Sauter; Hartwig Huland; Robert Kypta; Udo Schumacher; Tobias Lange
Journal:  Mol Oncol       Date:  2021-02-17       Impact factor: 6.603

10.  Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.

Authors:  Ricardo L Favaretto; Atessa Bahadori; Romain Mathieu; Andrea Haitel; Bernhard Grubmüller; Vitaly Margulis; Jose A Karam; Morgan Rouprêt; Christian Seitz; Pierre I Karakiewicz; Isabela W Cunha; Stenio C Zequi; Christopher G Wood; Alon Z Weizer; Jay D Raman; Mesut Remzi; Nathalie Rioux-Leclercq; Solene Jacquet-Kammerer; Karim Bensalah; Yair Lotan; Alexander Bachmann; Michael Rink; Alberto Briganti; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-29       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.